Yield10 Bioscience, Inc. announced that the company recently filed a request for a Regulatory Status Review (RSR) with USDA-APHIS Biotechnology Regulatory Services (?BRS?) under the Sustainable, Ecological, Consistent, Uniform, Responsible, Efficient (SECURE) Rule for proprietary elite Camelina sativa (Camelina) varieties designed to produce seed oil containing both essential omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The genetic pathway deployed in the omega-3 Camelina DHA1 line described in the Company?s RSR submission produces oil containing approximately 10% EPA and 10% DHA, closely resembling the omega-3 EPA/DHA fatty acid profile of northern hemisphere fish oil. Yield10 is making plans to conduct field work with omega-3 (EPA+DHA) Camelina with the goal to begin the ramp-up of seed inventory for future planting as well as to produce omega-3 oil for use in business development activities.

Currently, the primary source of the essential fatty acids EPA and DHA is ocean-caught fish, where omega-3 oil produced from anchovy harvest is the industry benchmark. Producing omega-3 fatty acids in Camelina represents a potential way to enable a reliable supply of high-quality omega-3 oils to meet the global demand for EPA and DHA. In 2020, Yield10 signed an exclusive collaboration agreement with Rothamsted to support Rothamsted?s Flagship Program to develop omega-3 oils in Camelina.

As part of the collaboration agreement, the Company received an exclusive option to sign a global, exclusive license agreement for the technology. Yield10 recently announced it had exercised this option and plans to finalize [1] the global exclusive license with Rothamsted. Yield10 prioritized development and scale-up of EPA omega-3 Camelina and filed an RSR [2] for approval of this line for production in the United States with USDA-APHIS in 2023.

Yield10 planted omega-3 (EPA) Camelina at acre-scale in Chile during the fourth quarter of 2023 to begin the ramp-up of seed inventory for future planting, as well as to produce omega-3 (EPA) oil samples for business development activities. Following immediately behind the EPA Camelina, Yield10 is scaling up an omega-3 Camelina line to produce oil containing both EPA and DHA fatty acids. This line has been extensively tested by Rothamsted and published aquafeed studies have shown that the EPA + DHA oil produced in Camelina has the potential to serve as a drop-in replacement for fish oil.

Furthermore, published human clinical studies have shown this oil to be an effective alternative to fish oil in the human diet. The SECURE Rule was published on May 18, 2020 and represents the first comprehensive revision of APHIS? biotechnology regulations since 1987.

The revisions enable APHIS to regulate organisms developed using genetic engineering for plant pest risk with greater precision and reduces the regulatory burden for developers of organisms that are unlikely to pose plant pest risks. Once a specific plant developed through genetic engineering is found not to require regulation, new varieties of the plant containing the same genetic modification would similarly not be regulated. Camelina plants containing omega-3 traits are subject to regulation by the U.S. Food and Drug Administration.